Lung inflammation and fibrosis: An alveolar macrophage-centered perspective from the 1970s to 1980s

American Journal of Respiratory and Critical Care Medicine

Volumn 171, Issue 2, 2005, Pages 98-102

  Reynolds, Herbert Y ^a,b,c  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c DLD/NHLBI   (United States)

Author keywords

Cytokines chemokines; Effector immune function

Indexed keywords

ARACHIDONIC ACID; CALCIMYCIN; CALCIUM IONOPHORE; CHEMOKINE; CHEMOTACTIC FACTOR; CHEMOTAXIN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C5; COMPLEMENT COMPONENT C5A; CORTICOSTEROID; GAMMA INTERFERON; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN 8; LEUKOTRIENE B4; LEUKOTRIENE C4; LIPOXYGENASE; ZYMOSAN;

AUSCULTATION; CELLULAR IMMUNITY; CHEMOTAXIS; FIBEROPTIC BRONCHOSCOPY; HOST RESISTANCE; HUMAN; IN VITRO STUDY; LOBAR PNEUMONIA; LUNG ALVEOLUS; LUNG ALVEOLUS MACROPHAGE; LUNG FIBROSIS; LUNG INFECTION; LUNG LAVAGE; NONHUMAN; PATHOLOGY; PHAGOCYTE; PHAGOCYTOSIS; PNEUMONIA; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REVIEW; STAPHYLOCOCCUS ALBUS; TUBERCULOSIS;

HUMANS; IMMUNITY, NATURAL; INTERLEUKIN-8; LEUKOTRIENE B4; MACROPHAGES, ALVEOLAR; PNEUMONIA; PULMONARY FIBROSIS;

EID: 12144256583     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.200406-788PP     Document Type: Review

References (61)

1. Laënnec RTH. De l'ausculatation médiate ou Traité du diagnostic des maladies des poumons et du coeur, fondé principalement sur ce nouveau moyen d'exploration. Paris: Brosson & Chaudé, 1819; 1: 1-456 (pneumonia 1: 160-169).
2. Laënnec RTH. De l'ausculatation médiate ou Traité du diagnostic des maladies des poumons et du coeur, fondé principalement sur ce nouveau moyen d'exploration. Paris: Brosson & Chaudé, 1819; 1: 1-456 (pneumonia 1: 160-169).
3. Simmons JG. Doctors and discoveries: lives that created today's medicine. Boston: Houghton Mifflin; 2002. Rudolf Virchow (1821-1902) - the scope of modern medicine: cellular and social; p. 8-13.
4. Simmons JG. Doctors and discoveries: lives that created today's medicine. Boston: Houghton Mifflin; 2002. Elie Metchnikoff (1845-1916) - cellular immunity; p. 186-190.
5. Osler W. The principles and practice of medicine: designed for the use of practitioners and students of medicine. New York: D. Appleton and Company; 1892. Section IV, Diseases of the Respiratory System; 1. Circulatory Disturbances in the Lungs; 2. Pneumonia - Morbid Anatomy, p. 514-515.
6. Stillman EG. The presence of bacteria in the lungs of mice following inhalation. J Exp Med 1923;38:117-126.
7. Green GM, Kass EH. The role of the alveolar macrophage in clearance of bacteria from the lung. J Exp Med 1964;119:167-175.
8. Green GM. The J. Burns Amberson Lecture. In defense of the lung. Am Rev Respir Dis 1970;102:691-703.
9. McNess P. 50 years of clinical research at the NIH Clinical Center. Pioneering in immunology. Warren Grant Magnuson Clinical Center, National Institutes of Health, US Department of Health and Human Services, 2003; p. 69-71.
10. Myrvik QN, Leake ES, Fariss B. Studies on pulmonary alveolar macrophages from the normal rabbit: a technique to procure them in a high state of purity. J Immunol 1961;86:128-132.
11. Oren R, Farnham AE, Saito K, Milofsky E, Karnovsky ML. Metabolic patterns in three types of phagocytizing cells. J Cell Biol 1963;17:487-501.
12. Pennington JE, Reynolds HY, Carbone PP. Pseudomonas pneumonia: a retrospective study of thirty-six cases. Am J Med 1973;55:155-160.
13. Reynolds HY, Thompson RE. Pulmonary host defenses: I. Analysis of protein and lipids in bronchial secretions and antibody responses after vaccination with Pseudomonas aeruginosa. J Immunol 1973;111:358-368.
14. Reynolds HY, Thompson RE, Devlin HB. Development of cellular and humoral immunity in the respiratory tract of rabbits to Pseudomonas lipopolysaccharide. J Clin Invest 1974;53:1351-1358.
15. Kazmierowski JA, Fauci AS, Reynolds HY. Characterization of lymphocytes in bronchial lavage fluid from monkeys. J Immunol 1976;116:615-618.
16. Reynolds HY, Newball HH. Analysis of proteins and respiratory cells obtained from human lungs by bronchial lavage. J Lab Clin Med 1974;84:559-573.
17. Reynolds HY. Use of bronchoalveolar lavage in humans: past necessity and future imperative. Lung 2000;178:271-293.
18. Finley TN, Swenson EW, Curran WS, Huber GL, Ladman AJ. Bronchopulmonary lavage in normal subjects and patients with obstructive lung disease. Ann Intern Med 1967;66:651-658.
19. Harris JO, Swenson EW, Johnson JE III. Human alveolar macrophages: comparison of phagocytic ability, glucose utilization, and ultrastructure in smokers and nonsmokers. J Clin Invest 1970;49:2086-2096.
20. Cohen AB, Cline MJ. The human alveolar macrophage: isolation, cultivation in vitro and studies of morphologic and functional characteristics. J Clin Invest 1971;50:1390-1398.
21. Cantrell ET, Warr GA, Busbee DL, Martin RR. Induction of aryl hydrocarbon hydroxylase in human pulmonary alveolar macrophages by cigarette smoking. J Clin Invest 1973;52:1881-1884.
22. Yeager H Jr, Zimmet SM, Schwartz SL. Pinocytosis by human alveolar macrophages: comparison of smokers and nonsmokers. J Clin Invest 1974;54:247-251.
23. Reynolds HY, Atkinson JP, Newball HH, Frank MM. Receptors for immunoglobulin and complement on human alveolar macrophages. J Immunol 1975;114:1813-1819.
24. Reynolds HY, Kazmierowski JA, Newball HH. Specificity of opsonic antibodies to enhance phagocytosis of Pseudomonas aeruginosa by human alveolar macrophages. J Clin Invest 1975;56:376-385.
25. Daniele RP, Altose MD, Rowland DR Jr. Immunocompetent cells from the lower respiratory tract of normal human lungs. J Clin Invest 1975;56:986-995.
26. Ward PA, Hunninghake GW. Lung inflammation and fibrosis. Supplement: advances in pulmonary biology and medicine - celebrating fifty years at NHLBI. Am J Respir Crit Care Med 1998;157:S123-S129.
27. Nathan CF, Murray HW, Cohn ZA. The macrophage as an effector cell - current concepts. N Engl J Med 1980;303:622-626.
28. Cohen AB, Batra G, Peterson R. Size of the pool of alveolar neutrophils in normal rabbit lungs. J Appl Physiol 1979;47:440-444.
29. Kazmierowski JA, Gallin JI, Reynolds HY. Mechanisms for the inflammatory response in primate lungs: demonstration and partial characterization of an alveolar macrophage-derived chemotactic factor with preferential activity for polymorphonuclear leukocytes. J Clin Invest 1977;59:273-281.
30. Ward PA, Zvaifler NJ. Quantitative phaocytosis by neutrophils: II. Release of the C5-cleaving enzyme and inhibition of phagocytosis by rheumatoid factor. J Immunol 1973;111:1777-1782.
31. Hunninghake GW, Gallin JI, Fauci AA. Immunologic reactivity in the lung: the in vivo and in vitro generation of a neutrophil chemotactic factor by alveolar macrophages. Am Rev Respir Dis 1978;117:15-23.
32. Gadek JE, Hunninghake GW, Zimmerman RL, Crystal RG. Regulation of the release of alveolar macrophage-derived neutrophil chemotactic factor. Am Rev Respir Dis 1980;121:723-733.
33. Merrill WW, Naegel GP, Matthay RA, Reynolds HY. Alveolar macrophage-derived chemotactic factor. J Clin Invest 1980;65:268-276.
34. Hunninghake GW, Gadek JE, Fales HM, Crystal RG. Human alveolar macrophage-derived chemotactic factor for neutrophils. J Clin Invest 1980;66:473-483.
35. Pennington JE, Rossing TH, Boerth LW, Lee TH. Isolation and partial characterization of a human alveolar macrophage-derived neutrophil-activating factor. J Clin Invest 1985;75:1230-1237.
36. Fels AOS, Pawlowski NA, Cramer EB, King TKC, Cohn ZA, Scott WA. Human alveolar macrophages produce leukotriene B4. Proc Natl Acad Sci USA 1982;79:7866-7870.
37. Rankin JA, Hitchock M, Merrill W, Bach MK, Brashler JR, Askenase PW. IgE- dependent release of leukotriene C4 from alveolar macrophages. Nature 1982;297:329-331.
38. Martin TR, Raugi G, Merritt TL, Henderson WR. Relative contribution of leukotriene B4 to the neutrophil chemotactic activity produced by the resident human alveolar macrophage. J Clin Invest 1987;80:1114-1124.
39. Rankin JA, Schrader CE, Smith SM, Lewis RA. Recombinant interferon-gamma primes alveolar macrophages cultured in vitro for the release of leukotriene B4 in response to IgG stimulation. J Clin Invest 1989;83:1691-1700.
40. Sylvester I, Rankin JA, Yoshimura T, Tanaka S, Leonard EJ. Secretion of neutrophil attractant/activation protein by lipopolysaccharide-stimulated lung macrophages determined by both enzyme-linked immunosorbent assay and n-terminal sequence analysis. Am Rev Respir Dis 1990;141:683-688.
41. Rankin JA, Sylvester I, Smith S, Yoshimura T, Leonard EJ. Macrophages cultured in vitro release leukotriene B4 and neutrophil attractant/activation protein (interleukin 8) sequentially in response to stimulation with lipopolysaccharide and zymosan. J Clin Invest 1990;86:1556-1564.
42. Baggiolini M, Walz A, Kunkel SL. Neutrophil-activating peptide-1/interleukin-8, a novel cytokine that activates neutrophils. J Clin Invest 1989;84:1045-1049.
43. Sibille Y, Reynolds HY. Macrophages and polymorphonuclear neutrophils in lung disease and injury: State of the Art. Am Rev Respir Dis 1990;144:471-501.
44. Strieter RM, Kunkel SL. Acute lung injury: the role of cytokines in the elicitation of neutrophils. J Invest Med 1994;42:640-651.
45. Sibille Y, Merrill WW, Naegel GP, Care SB, Cooper JAD Jr. Reynolds HY. Human alveolar macrophages release a factor that inhibits phagocyte function. Am J Respir Cell Mol Biol 1989;1:407-416.
46. Cooper JAD Jr, Sibille Y, Sitnik RJ, Bayles G, Buck MG, Merrill WW. Isolation of an inhibitor of neutrophil function from bronchial lavage of normal volunteers. Am J Physiol (Lung Cell Mol Physiol) 1991;260:L501-L509.
47. Cooper JAD Jr, Culbreth RR. Partial characterization of a neutrophil inhibitor peptide harvested from human bronchial lavage: homology to influenza A nucleoprotein. Am J Respir Cell Mol Biol 1996;15:207-215.
48. Cooper JAD Jr, Carcelen R, Culbreth RR. Effects of influenza A nucleoprotein on polymorphonuclear neutrophil function. J Infect Dis 1996;173:279-284.
49. Cooper JAD Jr, Ridgeway AL, Pearson J, Culbreth RR. Attenuation of interleukin 8-induced nasal inflammation by an inhibitor protein. Am J Respir Crit Care Med 2001;163:1198-1205.
50. Crystal RG, Fulmer JD, Roberts WC, Moss ML, Line BR, Reynolds HY. Idiopathic pulmonary fibrosis - clinical, histologic, radiographic, physiologic, scintigraphic, cytologic, and biochemical aspects. Ann Intern Med 1976;85:769-788.
51. Reynolds HY, Fulmer JD, Kazmierowski JA, Roberts WC, Frank MM, Crystal RG. Analysis of cellular and protein content of bronchoalveolar lavage fluid from patients with idiopathic pulmonary fibrosis and hypersensitivity pneumonitis. J Clin Invest 1977;59:165-175.
52. Haslam PL, Turton CWG, Lukoszek A, Salsbury AJ, Dewar A, Collins JV, Turner-Warwick M. Bronchoalveolar lavage fluid counts in cryptogenic fibrosing alveolitis and their relation to therapy. Thorax 1980;35:328-339.
53. Davis GS, Brody AR, Landis JN, Graham WGB, Craighead JE, Green GM. Quantitation of inflammatory activity in interstitial pneumonitis by bronchofiberscopic pulmonary lavage. 18th Aspen Lung Conf. Chest 1976;69:265-266.
54. Hunninghake GW, Gadek JE, Lawley TJ, Crystal RG. Mechanisms of neutrophil accumulation in the lungs of patients with pulmonary fibrosis. J Clin Invest 1981;68:259-269.
55. Carré PC, Mortenson RL, King TE Jr, Noble PW, Sable CL, Riches DWH. Increased expression of the interleukin-8 gene by alveolar macrophages in idiopathic pulmonary fibrosis: a potential mechanism for the recruitment and activation of neutrophils in lung fibrosis. J Clin Invest 1991;88:1802-1810.
56. Kuhn C III, Boldt J, King TE Jr, Crouch E, Vartio T, McDonald JA. An immunohistochemical study of architectural remodeling and connective tissue synthesis in pulmonary fibrosis. Am Rev Respir Dis 1989;140:1693-1703.
57. Liebow AA, Steer A, Billingsley JG. Desquamative Interstitial pneumonia. Am J Med 1965;38:369-404.
58. Katzenstein A-LA, Myers JL. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med 1998;157:1301-1315.
59. Katzenstein A-LA, Fiorelli RF. Non-specific interstitial pneumonia/fibrosis: histologic patterns and clinical significance. Am J Surg Pathol 1994;18:136-147.
60. Crystal RG, Bitterman PB, Mossman B, Schwarz MI, Sheppard D, Almasy L, Chapman HA, Friedman SL, King TE Jr, Leinwand LA, et al. Future research directions in idiopathic pulmonary fibrosis: summary of a National Heart, Lung and Blood Institute working group. Am J Respir Crit Care Med 2002;166:236-246.
61. King TE Jr, Costabel U, Cordier J-F, DoPico GA, duBois RM, Lynch D, Lynch JP, Myers J, Panos R, Raghu G, et al. Idiopathic pulmonary fibrosis: diagnosis and treatment (joint ATS and ERS statement). Am J Respir Crit Care Med 2000;161:646-664.